Global Oncology Drugs Market Research Report 2023(Status and Outlook)

Global Oncology Drugs Market Research Report 2023(Status and Outlook)



Report Overview

Cancer is the name given to a group of related diseases characterized by the uncontrolled and excessive growth of abnormal cells. More than 200 different types of cancer have been identified.

When these extra cells form a mass or a solid lump of tissue, it is called a tumor. Most cancers form tumors, but not all do. Tumors may be either benign or cancerous.

Benign tumors do not spread to other parts of the body and are rarely life-threatening. Many breast lumps, for example, are benign. Benign tumors are not cancer.

Malignant tumors crowd out healthy cells, interfere with body functions, and draw nutrients from body tissues. Malignant tumors can also spread to other parts of the body via the blood or lymphatic system, forming satellite tumors, called secondary cancers or metastases. Malignant tumors are cancer.

The Global Oncology Drugs Market Size was estimated at USD 197440.00 million in 2022 and is projected to reach USD 392160.39 million by 2029, exhibiting a CAGR of 10.30% during the forecast period.

Bosson Research’s latest report provides a deep insight into the global Oncology Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Oncology Drugs Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Oncology Drugs market in any manner.

Global Oncology Drugs Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Roche

Celgene

Novartis

Bristol-Myers Squibb

Johnson & Johnson

Merck & Co.

AstraZeneca

Pfizer

Amgen

Eli Lilly

AbbVie

Takeda

Astellas

Ipsen

Sanofi

Bayer

Biogen Idec

Teva

Otsuka

Eisai

Merck KGaA

Gilead Sciences

Market Segmentation (by Type)

Chemotherapy

Targeted Therapy

Immunotherapy (Biologic Therapy)

Hormonal Therapy

Others

Market Segmentation (by Application)

Health Care

Games and Entertainment

Communication

Other

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Oncology Drugs Market

Overview of the regional outlook of the Oncology Drugs Market:

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Oncology Drugs
1.2 Key Market Segments
1.2.1 Oncology Drugs Segment by Type
1.2.2 Oncology Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Oncology Drugs Market Overview
2.1 Global Market Overview
2.1.1 Global Oncology Drugs Market Size (M USD) Estimates and Forecasts (2018-2029)
2.1.2 Global Oncology Drugs Sales Estimates and Forecasts (2018-2029)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Oncology Drugs Market Competitive Landscape
3.1 Global Oncology Drugs Sales by Manufacturers (2018-2023)
3.2 Global Oncology Drugs Revenue Market Share by Manufacturers (2018-2023)
3.3 Oncology Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Oncology Drugs Average Price by Manufacturers (2018-2023)
3.5 Manufacturers Oncology Drugs Sales Sites, Area Served, Product Type
3.6 Oncology Drugs Market Competitive Situation and Trends
3.6.1 Oncology Drugs Market Concentration Rate
3.6.2 Global 5 and 10 Largest Oncology Drugs Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Oncology Drugs Industry Chain Analysis
4.1 Oncology Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Oncology Drugs Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Oncology Drugs Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Oncology Drugs Sales Market Share by Type (2018-2023)
6.3 Global Oncology Drugs Market Size Market Share by Type (2018-2023)
6.4 Global Oncology Drugs Price by Type (2018-2023)
7 Oncology Drugs Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Oncology Drugs Market Sales by Application (2018-2023)
7.3 Global Oncology Drugs Market Size (M USD) by Application (2018-2023)
7.4 Global Oncology Drugs Sales Growth Rate by Application (2018-2023)
8 Oncology Drugs Market Segmentation by Region
8.1 Global Oncology Drugs Sales by Region
8.1.1 Global Oncology Drugs Sales by Region
8.1.2 Global Oncology Drugs Sales Market Share by Region
8.2 North America
8.2.1 North America Oncology Drugs Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Oncology Drugs Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Oncology Drugs Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Oncology Drugs Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Oncology Drugs Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Roche
9.1.1 Roche Oncology Drugs Basic Information
9.1.2 Roche Oncology Drugs Product Overview
9.1.3 Roche Oncology Drugs Product Market Performance
9.1.4 Roche Business Overview
9.1.5 Roche Oncology Drugs SWOT Analysis
9.1.6 Roche Recent Developments
9.2 Celgene
9.2.1 Celgene Oncology Drugs Basic Information
9.2.2 Celgene Oncology Drugs Product Overview
9.2.3 Celgene Oncology Drugs Product Market Performance
9.2.4 Celgene Business Overview
9.2.5 Celgene Oncology Drugs SWOT Analysis
9.2.6 Celgene Recent Developments
9.3 Novartis
9.3.1 Novartis Oncology Drugs Basic Information
9.3.2 Novartis Oncology Drugs Product Overview
9.3.3 Novartis Oncology Drugs Product Market Performance
9.3.4 Novartis Business Overview
9.3.5 Novartis Oncology Drugs SWOT Analysis
9.3.6 Novartis Recent Developments
9.4 Bristol-Myers Squibb
9.4.1 Bristol-Myers Squibb Oncology Drugs Basic Information
9.4.2 Bristol-Myers Squibb Oncology Drugs Product Overview
9.4.3 Bristol-Myers Squibb Oncology Drugs Product Market Performance
9.4.4 Bristol-Myers Squibb Business Overview
9.4.5 Bristol-Myers Squibb Oncology Drugs SWOT Analysis
9.4.6 Bristol-Myers Squibb Recent Developments
9.5 Johnson andamp; Johnson
9.5.1 Johnson andamp; Johnson Oncology Drugs Basic Information
9.5.2 Johnson andamp; Johnson Oncology Drugs Product Overview
9.5.3 Johnson andamp; Johnson Oncology Drugs Product Market Performance
9.5.4 Johnson andamp; Johnson Business Overview
9.5.5 Johnson andamp; Johnson Oncology Drugs SWOT Analysis
9.5.6 Johnson andamp; Johnson Recent Developments
9.6 Merck andamp; Co.
9.6.1 Merck andamp; Co. Oncology Drugs Basic Information
9.6.2 Merck andamp; Co. Oncology Drugs Product Overview
9.6.3 Merck andamp; Co. Oncology Drugs Product Market Performance
9.6.4 Merck andamp; Co. Business Overview
9.6.5 Merck andamp; Co. Recent Developments
9.7 AstraZeneca
9.7.1 AstraZeneca Oncology Drugs Basic Information
9.7.2 AstraZeneca Oncology Drugs Product Overview
9.7.3 AstraZeneca Oncology Drugs Product Market Performance
9.7.4 AstraZeneca Business Overview
9.7.5 AstraZeneca Recent Developments
9.8 Pfizer
9.8.1 Pfizer Oncology Drugs Basic Information
9.8.2 Pfizer Oncology Drugs Product Overview
9.8.3 Pfizer Oncology Drugs Product Market Performance
9.8.4 Pfizer Business Overview
9.8.5 Pfizer Recent Developments
9.9 Amgen
9.9.1 Amgen Oncology Drugs Basic Information
9.9.2 Amgen Oncology Drugs Product Overview
9.9.3 Amgen Oncology Drugs Product Market Performance
9.9.4 Amgen Business Overview
9.9.5 Amgen Recent Developments
9.10 Eli Lilly
9.10.1 Eli Lilly Oncology Drugs Basic Information
9.10.2 Eli Lilly Oncology Drugs Product Overview
9.10.3 Eli Lilly Oncology Drugs Product Market Performance
9.10.4 Eli Lilly Business Overview
9.10.5 Eli Lilly Recent Developments
9.11 AbbVie
9.11.1 AbbVie Oncology Drugs Basic Information
9.11.2 AbbVie Oncology Drugs Product Overview
9.11.3 AbbVie Oncology Drugs Product Market Performance
9.11.4 AbbVie Business Overview
9.11.5 AbbVie Recent Developments
9.12 Takeda
9.12.1 Takeda Oncology Drugs Basic Information
9.12.2 Takeda Oncology Drugs Product Overview
9.12.3 Takeda Oncology Drugs Product Market Performance
9.12.4 Takeda Business Overview
9.12.5 Takeda Recent Developments
9.13 Astellas
9.13.1 Astellas Oncology Drugs Basic Information
9.13.2 Astellas Oncology Drugs Product Overview
9.13.3 Astellas Oncology Drugs Product Market Performance
9.13.4 Astellas Business Overview
9.13.5 Astellas Recent Developments
9.14 Ipsen
9.14.1 Ipsen Oncology Drugs Basic Information
9.14.2 Ipsen Oncology Drugs Product Overview
9.14.3 Ipsen Oncology Drugs Product Market Performance
9.14.4 Ipsen Business Overview
9.14.5 Ipsen Recent Developments
9.15 Sanofi
9.15.1 Sanofi Oncology Drugs Basic Information
9.15.2 Sanofi Oncology Drugs Product Overview
9.15.3 Sanofi Oncology Drugs Product Market Performance
9.15.4 Sanofi Business Overview
9.15.5 Sanofi Recent Developments
9.16 Bayer
9.16.1 Bayer Oncology Drugs Basic Information
9.16.2 Bayer Oncology Drugs Product Overview
9.16.3 Bayer Oncology Drugs Product Market Performance
9.16.4 Bayer Business Overview
9.16.5 Bayer Recent Developments
9.17 Biogen Idec
9.17.1 Biogen Idec Oncology Drugs Basic Information
9.17.2 Biogen Idec Oncology Drugs Product Overview
9.17.3 Biogen Idec Oncology Drugs Product Market Performance
9.17.4 Biogen Idec Business Overview
9.17.5 Biogen Idec Recent Developments
9.18 Teva
9.18.1 Teva Oncology Drugs Basic Information
9.18.2 Teva Oncology Drugs Product Overview
9.18.3 Teva Oncology Drugs Product Market Performance
9.18.4 Teva Business Overview
9.18.5 Teva Recent Developments
9.19 Otsuka
9.19.1 Otsuka Oncology Drugs Basic Information
9.19.2 Otsuka Oncology Drugs Product Overview
9.19.3 Otsuka Oncology Drugs Product Market Performance
9.19.4 Otsuka Business Overview
9.19.5 Otsuka Recent Developments
9.20 Eisai
9.20.1 Eisai Oncology Drugs Basic Information
9.20.2 Eisai Oncology Drugs Product Overview
9.20.3 Eisai Oncology Drugs Product Market Performance
9.20.4 Eisai Business Overview
9.20.5 Eisai Recent Developments
9.21 Merck KGaA
9.21.1 Merck KGaA Oncology Drugs Basic Information
9.21.2 Merck KGaA Oncology Drugs Product Overview
9.21.3 Merck KGaA Oncology Drugs Product Market Performance
9.21.4 Merck KGaA Business Overview
9.21.5 Merck KGaA Recent Developments
9.22 Gilead Sciences
9.22.1 Gilead Sciences Oncology Drugs Basic Information
9.22.2 Gilead Sciences Oncology Drugs Product Overview
9.22.3 Gilead Sciences Oncology Drugs Product Market Performance
9.22.4 Gilead Sciences Business Overview
9.22.5 Gilead Sciences Recent Developments
10 Oncology Drugs Market Forecast by Region
10.1 Global Oncology Drugs Market Size Forecast
10.2 Global Oncology Drugs Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Oncology Drugs Market Size Forecast by Country
10.2.3 Asia Pacific Oncology Drugs Market Size Forecast by Region
10.2.4 South America Oncology Drugs Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Oncology Drugs by Country
11 Forecast Market by Type and by Application (2024-2029)
11.1 Global Oncology Drugs Market Forecast by Type (2024-2029)
11.1.1 Global Forecasted Sales of Oncology Drugs by Type (2024-2029)
11.1.2 Global Oncology Drugs Market Size Forecast by Type (2024-2029)
11.1.3 Global Forecasted Price of Oncology Drugs by Type (2024-2029)
11.2 Global Oncology Drugs Market Forecast by Application (2024-2029)
11.2.1 Global Oncology Drugs Sales (K MT) Forecast by Application
11.2.2 Global Oncology Drugs Market Size (M USD) Forecast by Application (2024-2029)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings